Cargando…
Five‐year follow‐up of a phase II study of DA‐EPOCH‐R with high‐dose MTX in CD5‐positive DLBCL
Autores principales: | Miyazaki, Kana, Sakai, Rika, Iwaki, Noriko, Yamamoto, Go, Murayama, Kayoko, Nishikori, Momoko, Sunami, Kazutaka, Yoshida, Isao, Yano, Hiroki, Takahashi, Naoki, Okamoto, Akinao, Munemoto, Saori, Sawazaki, Aiko, Suehiro, Youko, Fukuhara, Noriko, Wake, Atsushi, Arai, Ayako, Masaki, Yasufumi, Toyama, Kohtaro, Yokoyama, Akihiro, Tsunemine, Hiroko, Hasegawa, Yuichi, Matsumoto, Kenji, Yamada, Tomomi, Nishimura, Yuki, Tamaru, Satoshi, Asano, Naoko, Miyawaki, Kohta, Izutsu, Koji, Kinoshita, Tomohiro, Suzuki, Ritsuro, Ohshima, Koichi, Kato, Koji, Katayama, Naoyuki, Yamaguchi, Motoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236623/ https://www.ncbi.nlm.nih.gov/pubmed/36929591 http://dx.doi.org/10.1111/cas.15784 |
Ejemplares similares
-
DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study
por: Miyazaki, Kana, et al.
Publicado: (2019) -
S5-KL-1 CURRENT TREATMENT FOR DLBCL AND PROPHYLAXIS AND TREATMENT FOR SECONDARY CNS LYMPHOMA
por: Izutsu, Koji
Publicado: (2019) -
Lymphoma Microenvironment in DLBCL and PTCL-NOS: the key to uncovering heterogeneity and the potential for stratification
por: Miyawaki, Kohta, et al.
Publicado: (2022) -
Parsaclisib in Japanese patients with relapsed or refractory B‐cell lymphoma (CITADEL‐111): A phase Ib study
por: Fukuhara, Noriko, et al.
Publicado: (2022) -
Real-world efficacy of DA-EPOCH-R/HD-MTX regimen in CD5-positive diffuse large B cell lymphoma: a single-institute analysis
por: Toyama, Kohtaro, et al.
Publicado: (2023)